Latest News

Tuesday, September 26, 2017 | Partnerships, Psivida

pSivida Partners with Global Pharmaceuticals Company to Develop Sustained Release Formulations of Glaucoma Drugs

pSivida Corp. has signed an agreement with a major global pharmaceutical company to develop two glaucoma drugs with pSivida's proprietary sustained-release technology. This agreement builds upon t…

Read the full story

Tuesday, September 26, 2017 | Product Releases

Vino Optics Announces Hospital Subscription Plan for Medical Protective Eyewear that Enhance Vein Detection

Medical personnel who want to better see blood under a patient’s skin can now enroll in Vino Optics’ subscription plan for hospitals. The plan gives hospital nurses, doctors, paramedics an…

Read the full story

Tuesday, September 26, 2017 | Earnings & Financials, Allergan

Allergan Authorizes New $2 Billion Share Repurchase Program

Allergan announced that the company's board of directors has authorized a new $2 billion share repurchase program, and has affirmed its commitment to increasing its regular quarterly cash dividend…

Read the full story

Monday, September 25, 2017 | Partnerships, Alcon

Alcon Teams Up With US Olympians Laurie Hernandez and Tobin Heath to Launch the Dailies Invisible Edge Campaign

Alcon is launching a new consumer education campaign called "Invisible Edge" with the help of Olympic gold- and silver-medalist Laurie Hernandez and two-time gold-medalist Tobin Heath. These…

Read the full story

Monday, September 25, 2017 | Product Releases

New Ophthalmic Company Eyevance Pharmaceuticals Enters into an Exclusive Licensing Agreement for Zerviate

Eyevance Pharmaceuticals has entered into an exclusive licensing agreement with Nicox Ophthalmics, a subsidiary of Nicox S.A., in which Eyevance received commercialization rights to Zerviate (cetirizi…

Read the full story

Monday, September 25, 2017 | FDA Approval/Clearance

Ampleye Scleral Contact Lens Now FDA Approved for Ocular Surface & Dry Eye Disease Management

Art Optical Contact Lens has received 510(k) clearance from the FDA on their Ampleye Scleral lens for the therapeutic management of ocular surface disease from dry eye. The specific therapeutic ind…

Read the full story

Monday, September 25, 2017 | Clinical Trials

Ocugen Announces FDA Acceptance of Investigational New Drug Application for OCU310 and Initiates Proof of Concept Study for Treatment of Dry Eye Disease

Ocugen announced that the FDA accepted its investigational new drug (IND) application for OCU310 (brimonidine/steroid combination therapy), a topical formulation for the treatment of dry eye disease (…

Read the full story

Monday, September 25, 2017 | Awards

The American Academy of Optometry Foundation Announces the 2017 Alfred A. Rosenbloom Jr. Low Vision Residency Award Recipient

Rachel Young, OD, low vision, traumatic brain injury, and primary care resident at the VA Long Beach Medical Center was chosen by a committee of members in the Low Vision Section of the American Acade…

Read the full story

Monday, September 25, 2017 | Management/Leadership, Ocular Therapeutix

Ocular Therapeutix Appoints Donald Notman as Chief Financial Officer

Ocular Therapeutix announced the appointment of Donald Notman as Chief Financial Officer, effective immediately. Mr. Notman will replace interim CFO George Migausky and will be responsible for all str…

Read the full story

Monday, September 25, 2017 | Medical Studies

Bariatric Surgery May Reduce Retinopathy Risk, Progression

Roux-en-Y gastric bypass (RYGB) surgery reduces the risk for retinopathy in obese patients with type 2 diabetes, whether or not they experience diabetes remission following the operation, new research…

Read the full story

Friday, September 22, 2017 | Management/Leadership, SightLife Surgical

Robert J. Stevens Joins SightLife Surgical as Chief Technology Officer

SightLife Surgical announced that Bob Stevens has joined the company as its first Chief Technology Officer. In his new position, Bob will lead all product research and development, ensuring that the r…

Read the full story

Friday, September 22, 2017 | Awards

The American Academy of Optometry Foundation Selects the 2017 Douglas W. Hopkins Primary Care Residency Award Recipient

Ashley Rose Luke, OD, BS, primary care/ocular disease resident at the Zuni Comprehensive Community Health Center and graduate of Southern California College of Optometry at Marshall B. Ketchum Univers…

Read the full story

Friday, September 22, 2017 | Medical Studies

J-DOIT3: 'Aim for Near-Normal Metabolic Parameters' in Diabetes

Intensive control of blood pressure, glucose, and lipids benefits patients with type 2 diabetes, the long-awaited, large Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of C…

Read the full story

Thursday, September 21, 2017 | Product Releases, Johnson & Johnson Vision Care

Johnson & Johnson Vision Expands Monthly Offering with Acuvue Vita Brand Contact Lenses for Astigmatism

Johnson & Johnson Vision announced the US launch of Acuvue Vita brand contact lenses for astigmatism, a daily wear, monthly replacement contact lens with "Blink-Stabilized" design and &q…

Read the full story

Thursday, September 21, 2017 | Product Releases

Ophthalmic Resources Announces Launch of Dry Eye Disease Electronic Diagnostic Algorithm

Ophthalmic Resources announced that the electronic diagnostic algorithm (OSData) and blink analyzer (IPEDA), developed by founders Doug Devries, OD, and Paul Karpecki, OD, FAAO, is ready for release t…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $50.95  -2.77% 
 Akorn, Inc. $33.08  -0.11% 
 Alimera Sciences, Inc. $1.37  1.48% 
 Allergan $209.52  -0.99% 
 Applied Genetic Technologies $3.60  -1.37% 
 Bayer $33.13  -0.06% 
 Can-Fite Biopharma $1.69  -2.32% 
 Carl Zeiss Meditec $42.37  0.71% 
 Clearside Biomedical $8.18  -1.45% 
 Cooper Companies, Inc. $237.64  -0.92% 
 Eleven Biotherapeutics $1.59  -0.63% 
 Escalon Medical Corp. $0.12  -14.29% 
 Essilor International $103.25  -1.57% 
 Glaukos $32.39  3.63% 
 Imprimis Pharmaceuticals, Inc. $1.66  -3.78% 
 Inotek Pharmaceuticals $1.67  1.83% 
 IRIDEX Corporation $9.33  0.76% 
 Johnson & Johnson $131.41  0.18% 
 Luxottica Group, S.p.A. $60.90  0.41% 
 Merck & Company, Inc. $64.85  -0.51% 
 NicOx $9.40  -3.27% 
 NovaBay Pharmaceuticals, Inc. $4.55  1.11% 
 Novartis AG Common Stock $85.19  -1.21% 
 Ocular Therapeutix $6.37  0.00% 
 Ophthotech Corporation $2.77  -0.54% 
 Quantel $6.54  1.40% 
 Regeneron $435.26  -0.66% 
 Roche $31.80  -0.62% 
 Second Sight Medical Products $1.21  -0.82% 
 Shire $150.76  -2.50% 
 Spark Therapeutics, Inc. $85.76  -1.43% 
 STAAR Surgical Company $11.98  0.63% 
 TearLab Corporation $1.35  0.75% 
 Thrombogenics $3.80  -1.43% 
 Valeant Pharmaceuticals $14.02  -0.50% 
 Xoma $19.26  -0.72%